These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 30105672)

  • 1. Telmisartan Protects a Microglia Cell Line from LPS Injury Beyond AT1 Receptor Blockade or PPARγ Activation.
    Elkahloun AG; Rodriguez Y; Alaiyed S; Wenzel E; Saavedra JM
    Mol Neurobiol; 2019 May; 56(5):3193-3210. PubMed ID: 30105672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telmisartan ameliorates Aβ oligomer-induced inflammation via PPARγ/PTEN pathway in BV2 microglial cells.
    Wang ZF; Li J; Ma C; Huang C; Li ZQ
    Biochem Pharmacol; 2020 Jan; 171():113674. PubMed ID: 31634455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease.
    Garrido-Gil P; Joglar B; Rodriguez-Perez AI; Guerra MJ; Labandeira-Garcia JL
    J Neuroinflammation; 2012 Feb; 9():38. PubMed ID: 22356806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telmisartan directly ameliorates the neuronal inflammatory response to IL-1β partly through the JNK/c-Jun and NADPH oxidase pathways.
    Pang T; Wang J; Benicky J; Sánchez-Lemus E; Saavedra JM
    J Neuroinflammation; 2012 May; 9():102. PubMed ID: 22642771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of telmisartan on nitric oxide--asymmetrical dimethylarginine system: role of angiotensin II type 1 receptor gamma and peroxisome proliferator activated receptor gamma signaling during endothelial aging.
    Scalera F; Martens-Lobenhoffer J; Bukowska A; Lendeckel U; Täger M; Bode-Böger SM
    Hypertension; 2008 Mar; 51(3):696-703. PubMed ID: 18250362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telmisartan ameliorates glutamate-induced neurotoxicity: roles of AT(1) receptor blockade and PPARγ activation.
    Wang J; Pang T; Hafko R; Benicky J; Sanchez-Lemus E; Saavedra JM
    Neuropharmacology; 2014 Apr; 79():249-61. PubMed ID: 24316465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: possible involvement of different binding sites at the PPARγ receptor.
    García C; Gómez-Cañas M; Burgaz S; Palomares B; Gómez-Gálvez Y; Palomo-Garo C; Campo S; Ferrer-Hernández J; Pavicic C; Navarrete C; Luz Bellido M; García-Arencibia M; Ruth Pazos M; Muñoz E; Fernández-Ruiz J
    J Neuroinflammation; 2018 Jan; 15(1):19. PubMed ID: 29338785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telmisartan ameliorates lipopolysaccharide-induced innate immune response through peroxisome proliferator-activated receptor-γ activation in human monocytes.
    Pang T; Benicky J; Wang J; Orecna M; Sanchez-Lemus E; Saavedra JM
    J Hypertens; 2012 Jan; 30(1):87-96. PubMed ID: 22124178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telmisartan-induced inhibition of vascular cell proliferation beyond angiotensin receptor blockade and peroxisome proliferator-activated receptor-gamma activation.
    Yamamoto K; Ohishi M; Ho C; Kurtz TW; Rakugi H
    Hypertension; 2009 Dec; 54(6):1353-9. PubMed ID: 19822796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurorestoration after traumatic brain injury through angiotensin II receptor blockage.
    Villapol S; Balarezo MG; Affram K; Saavedra JM; Symes AJ
    Brain; 2015 Nov; 138(Pt 11):3299-315. PubMed ID: 26115674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor gamma.
    Imayama I; Ichiki T; Inanaga K; Ohtsubo H; Fukuyama K; Ono H; Hashiguchi Y; Sunagawa K
    Cardiovasc Res; 2006 Oct; 72(1):184-90. PubMed ID: 16938288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telmisartan exerts renoprotective actions via peroxisome proliferator-activated receptor-γ/hepatocyte growth factor pathway independent of angiotensin II type 1 receptor blockade.
    Kusunoki H; Taniyama Y; Azuma J; Iekushi K; Sanada F; Otsu R; Iwabayashi M; Okayama K; Rakugi H; Morishita R
    Hypertension; 2012 Feb; 59(2):308-16. PubMed ID: 22252391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low dose of telmisartan prevents ischemic brain damage with peroxisome proliferator-activated receptor-gamma activation in diabetic mice.
    Iwanami J; Mogi M; Tsukuda K; Min LJ; Sakata A; Jing F; Iwai M; Horiuchi M
    J Hypertens; 2010 Aug; 28(8):1730-7. PubMed ID: 20498620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telmisartan prevention of LPS-induced microglia activation involves M2 microglia polarization via CaMKKβ-dependent AMPK activation.
    Xu Y; Xu Y; Wang Y; Wang Y; He L; Jiang Z; Huang Z; Liao H; Li J; Saavedra JM; Zhang L; Pang T
    Brain Behav Immun; 2015 Nov; 50():298-313. PubMed ID: 26188187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telmisartan protects against diabetic vascular complications in a mouse model of obesity and type 2 diabetes, partially through peroxisome proliferator activated receptor-γ-dependent activity.
    Toyama K; Nakamura T; Kataoka K; Yasuda O; Fukuda M; Tokutomi Y; Dong YF; Ogawa H; Kim-Mitsuyama S
    Biochem Biophys Res Commun; 2011 Jul; 410(3):508-13. PubMed ID: 21679694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II type 1 receptor blockade by telmisartan prevents stress-induced impairment of memory via HPA axis deactivation and up-regulation of brain-derived neurotrophic factor gene expression.
    Wincewicz D; Juchniewicz A; Waszkiewicz N; Braszko JJ
    Pharmacol Biochem Behav; 2016 Sep; 148():108-18. PubMed ID: 27375198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms.
    Yi JH; Park SW; Brooks N; Lang BT; Vemuganti R
    Brain Res; 2008 Dec; 1244():164-72. PubMed ID: 18948087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telmisartan attenuated LPS-induced neuroinflammation in human IMR-32 neuronal cell line via SARM in AT1R independent mechanism.
    Saravanan PB; Shanmuganathan MV; Ramanathan M
    Life Sci; 2015 Jun; 130():88-96. PubMed ID: 25816983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valsartan and telmisartan abrogate angiotensin II-induced downregulation of ABCA1 expression via AT1 receptor, rather than AT2 receptor or PPARγ activation.
    Chen HY; Xu Z; Chen LF; Wang W; Fang Q; Yan XW
    J Cardiovasc Pharmacol; 2012 Jun; 59(6):570-5. PubMed ID: 22392065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telmisartan inhibits microglia-induced neurotoxic A1 astrocyte conversion via PPARγ-mediated NF-κB/p65 degradation.
    Quan W; Xu CS; Li XC; Yang C; Lan T; Wang MY; Yu DH; Tang F; Wang ZF; Li ZQ
    Int Immunopharmacol; 2023 Oct; 123():110761. PubMed ID: 37544025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.